Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04035174

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Center for Research on Filariasis and Other Tropical Diseases, Cameroon · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study aims at evaluating the diagnosis performances of the LTS-2 DEC patch for onchocerciasis compared to the gold standard which are the skin snips. This study will be conducted in Cameroon in two different areas : Ngog-Mapubi and Bafia Health Districts (one area only endemic for onchocerciasis, and one area endemic for both loiasis and onchocerciasis).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLTS-2 DEC patchAfter 24 hours, the patch will be removed, and then the reaction of the skin under the device will be assessed : no reaction, weak reaction (\< 50% skin surface under the patch), medium reaction (\> 50% skin surface under the patch), and important reaction (reaction on all the surface of the skin under the patch).
DIAGNOSTIC_TESTSkin snipsRegarding skin snips, a reading will be done at 24 hours after incubation of the skin in saline serum during 24 hours.

Timeline

Start date
2022-09-01
Primary completion
2022-10-30
Completion
2023-03-30
First posted
2019-07-29
Last updated
2025-03-25

Locations

1 site across 1 country: Cameroon

Source: ClinicalTrials.gov record NCT04035174. Inclusion in this directory is not an endorsement.